CP320626
CP320626 is a potent inhibitor of human liver glycogen phosphorylase (IC50=205 nM) . CP320626 reduces blood glucose in diabetic mice without changing plasma insulin levels. CP320626 can be used in the study of type 2 diabetes[1].
Product Specifications
CAS Number
186430-23-9
UNSPSC
12352005
Target
Phosphorylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/cp320626.html
Smiles
O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=C(F)C=C3)C(N4CCC(O)CC4)=O
Molecular Formula
C23H23ClFN3O3
Molecular Weight
443.90
References & Citations
[1]Oikonomakos, et al. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure 8.6 (2000) : 575-584.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TMAB-10753-01 50 μL
Anti-Phospho-GRK2 (Ser29) Polyclonal Antibody 2
Sign In for Pricing
View Details TMAB-10753-02 100 µL
Anti-Phospho-GRK2 (Ser29) Polyclonal Antibody 2
Sign In for Pricing
View Details TMAB-10753-03 200 µL
Anti-Phospho-GRK2 (Ser29) Polyclonal Antibody 2
Sign In for Pricing
View Details 